“…According to US Food and Drug Administration (FDA) guidance on the control of L. monocytogenes in ready-to-eat foods, a listeristatic formulation that combines one or more antimicrobial substances is generally considered to be effective as a process control if growth studies that include samples at various points during product shelf life show an increase of <1 log 10 cycle over 2 or more time intervals (e.g., days, weeks, and so on, based on sampling plan) in the number of L. monocytogenes during replicate trials with the food of interest (FDA, 2017b). Several antimicrobials generally recognized as safe (GRAS) by the FDA including caprylic acid (CA; FDA, 2015), hydrogen peroxide (HP; FDA, 2015), lauric arginate (LAE;FDA, 2005a,b), and ε-polylysine (EPL; FDA, 2011) have demonstrated efficacy in controlling L. monocytogenes under varying experimental conditions (Luchansky et al, 2005;Amrouche et al, 2010;Kozak et al, 2017), including applications in milk (Romanova et al, 2002;Geornaras et al, 2007;Ma et al, 2013) and cheese (Soni et al, 2010;Gadotti et al, 2014). Limited data are available on the efficacy of sodium caprylate (SC) against L. monocytogenes (Kozak et al, 2017), but several fatty acid derivatives including SC have demonstrated antimicrobial effects against gram-positive bacteria (Kabara et al, 1972;Nair et al, 2004).…”